Contact
searchSearch
HMP Global

Transplant Topic Center

Featured Article

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network
News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network
PharmLaw
Louisiana Secures $45M Settlement With CVS, Caremark Over PBM Practices
03/04/2026
Grace Taylor, MS, MA
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million...
03/04/2026
Pharmacy Learning Network
PharmLaw
Federal Court Preliminarily Approves $5.275M Settlement in PharMerica Data Breach Class Action
02/27/2026
Grace Taylor, MS, MA
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has...
02/27/2026
Pharmacy Learning Network
News
Slate Run Pharmaceuticals Recalls Eptifibatide Injection Nationwide Over Carton Labeling Error
02/26/2026
Grace Taylor, MS, MA
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has...
02/26/2026
Pharmacy Learning Network
PharmLaw
Physician Sentenced in $145 Million Compound Cream Kickback Scheme Involving DOL-OWCP Billing
02/25/2026
Grace Taylor, MS, MA
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced...
02/25/2026
Pharmacy Learning Network
News
Thiamine HCl Sodium Chloride Injection Recalled for Lack of Sterility Assurance
02/19/2026
Hannah Musick
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine...
02/19/2026
Pharmacy Learning Network
News
FDA Class II Recall Issued for Oxycodone Hydrochloride
02/19/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug...
02/19/2026
Pharmacy Learning Network
PharmLaw
Atlantic Biologicals Enters Deferred Prosecution Agreement in Opioid Distribution Scheme
02/18/2026
Hannah Musick
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation...
02/18/2026
Pharmacy Learning Network

What's New?

News
Immunosuppressants After Solid Organ Transplant Carry Nutritional Implications
07/17/2024
Jolynn Tumolo
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid...
07/17/2024
Pharmacy Learning Network
News
Immunosuppressant Recalled
05/30/2024
Jolynn Tumolo
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling 1176 bottles of sirolimus tablets for failing to meet impurities/degradation specifications.
Dr Reddy’s Laboratories Inc. is...
05/30/2024
Pharmacy Learning Network
News
Pharmacies Are Turning Away Immunocompromised Patients Seeking Fourth COVID-19 Shot
01/26/2022
Liz Szabo
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from...
01/26/2022
Pharmacy Learning Network
News
Alemtuzumab-Based Induction Promising for Kidney Transplant
08/17/2014
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard...
08/17/2014
Pharmacy Learning Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use